On July 30, 2018 OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, reported that it will release its financial and operating results for the second quarter of 2018, ended June 30, 2018, on Tuesday, August 14, 2018, after the close of the U.S. financial markets (Press release, Oncocyte, JUL 30, 2018, View Source [SID1234527958]). The Company will host a conference call on Tuesday, August 14, 2018, at 4:30 pm ET / 1:30 pm PT to discuss the results along with recent corporate developments.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The dial-in number in the U.S./Canada is 800-458-4148; for international participants, the number is +1-323-794-2598. For all callers, please refer to Conference ID 5162879. To access the live webcast, go to the investor relations section on the Company’s website, View Source." target="_blank" title="View Source." rel="nofollow">View Source

A replay of the conference call will be available for seven business days beginning about two hours after the conclusion of the live call, by calling 888-203-1112 toll-free (from U.S./Canada); international callers dial 719-457-0820. Use the Conference ID 5162879. Additionally, the archived webcast will be available at View Source